4Blagat S, Gaiha M, Sharma VK, et al. A comparative evalvation of C-reactive protein as a short-term pronostic marker in severe unstable angina-a preliminary study[J]. J Assoc Physicians India, 2003,51 : 349.
5Woolman R J, Watts GF, Puddey IB, et al. Leukocyte count and vascu-1 arfunction in Type2 diabetic subjects with treated hyper tension [ J ]. Atherosclerosis, 2002, 163( 1 ) : 175.
1[1]Ross R. Atherosclerosis-an inflammatory disease[J]. N Engl J Med, 1999, 340(2): 115-126.
2[2]Ledue TB, Rifai N. High sensitivity immunoassays for C-reactive protein: promises and pitfalls[J]. Clin Chem Lab Med, 2001, 39(11):1171-1176.
3[3]Whicher J, Rifai N, Biasucci LM. Markers of the acute phase response in cardiovascular disease: an update[J].Clin Chem Lab Med, 2001, 39(11):1054-1064.
4[4]Rifai N, Ridker PM. High-sensitivity C-reactive protein:a novel and promising marker of coronary heart disease [J]. Clin Chem, 2001,47(3):403-411.
5[5]Morley JJ, Kushner I. Serum C-reactive protein levels in disease[J]. Ann N Y Acad Sci, 1982,389:406-418.
6[8]Rothkrantz-Kos S, Schmitz MP, Bekers O, et al. Highsensitivity C-reactive protein methods examined[J]. Clin Chem, 2002,48(2): 359-362.
7[9]Ferreiros ER, Boissonnet CP, Pizarro R, et al. Independent prognostic value of elevated C-reactive protein in unstable angina [J]. Circulation, 1999,100 (19):1958-1963.
8[10]Morrow DA, Rifai N, Antman EM, et al. C-Reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy[J]. J Am Coll Cardiol ,1998; 31(7): 1460 -1465.
9[11]de Winter RJ, Bholasingh R, Lijmer JG, et al. Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction[J]. Cardiovasc Res, 1999,42 (1):240-245.
10[12]Haverkate F, Thompson SG, Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group [J]. Lancet ,1997, 349(9050): 462-466.
6Cypryk K, Czupryniak L, Wilczyflski J, et al. Diabetes screening after gestational diabetes mellitus: poor performance of fasting plasma glucose[J]. Acta Diabetol, 2004, 41 (1):5.
7Voulgari C, Tentolouris N heart failure risk in normal Dilaveris P, et al. Increased weight people with metabolic syndrome compared with metabolically healthy obese individuals[J]. J Am Coll Cardiol, 2011, 58(13): 1343.
8Navarro JF, Mora C, Gomez M, et al. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of turnout necrosis factor - alpha and interleukin - 6 in type 2 diabetic patients [ J ]. Nephrol Dial Transplant. 2008, 23(3): 919.
9Ridker PM. High-Sensitivity C - reactive Protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease [J]. Circulation,2011, 103:1813 - 1818.
10Festa A, Agostino R, Tracy RP, et al. Elevated levels of acute phase pro- teins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes [ J]. Diabetes,2002,51 : 1131 - 1137.
